chr19-40843841-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_000762.6(CYP2A6):āc.1440T>Cā(p.Phe480=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000763 in 1,611,356 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0041 ( 10 hom., cov: 30)
Exomes š: 0.00042 ( 2 hom. )
Consequence
CYP2A6
NM_000762.6 synonymous
NM_000762.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.638
Genes affected
CYP2A6 (HGNC:2610): (cytochrome P450 family 2 subfamily A member 6) This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 19-40843841-A-G is Benign according to our data. Variant chr19-40843841-A-G is described in ClinVar as [Benign]. Clinvar id is 782344.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr19-40843841-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.638 with no splicing effect.
BS2
High AC in GnomAd4 at 615 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2A6 | NM_000762.6 | c.1440T>C | p.Phe480= | synonymous_variant | 9/9 | ENST00000301141.10 | NP_000753.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2A6 | ENST00000301141.10 | c.1440T>C | p.Phe480= | synonymous_variant | 9/9 | 1 | NM_000762.6 | ENSP00000301141 | P1 | |
CYP2A6 | ENST00000599960.1 | n.359T>C | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00408 AC: 614AN: 150472Hom.: 10 Cov.: 30
GnomAD3 genomes
AF:
AC:
614
AN:
150472
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000997 AC: 250AN: 250778Hom.: 1 AF XY: 0.000730 AC XY: 99AN XY: 135564
GnomAD3 exomes
AF:
AC:
250
AN:
250778
Hom.:
AF XY:
AC XY:
99
AN XY:
135564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000420 AC: 614AN: 1460766Hom.: 2 Cov.: 33 AF XY: 0.000355 AC XY: 258AN XY: 726710
GnomAD4 exome
AF:
AC:
614
AN:
1460766
Hom.:
Cov.:
33
AF XY:
AC XY:
258
AN XY:
726710
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00408 AC: 615AN: 150590Hom.: 10 Cov.: 30 AF XY: 0.00391 AC XY: 287AN XY: 73464
GnomAD4 genome
AF:
AC:
615
AN:
150590
Hom.:
Cov.:
30
AF XY:
AC XY:
287
AN XY:
73464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at